In Treatment of Diabetic kidney disease Diabetic kidney disease is a type of kidney disease that is caused by diabetes or an increase in blood sugar. This leads to damage to the kidney and as a result, kidneys fail to work. Kindsave Tablet prevents or slows down the damage of kidney cells and helps in the proper function of kidneys. It helps in the elimination of toxic materials such as urea from the kidneys and improves kidney function. The best way to prevent diabetes-related kidney disease is to maintain your blood sugar to an optimal level. A healthy lifestyle and taking your medicines as prescribed can help you achieve these goals and improve your health overall.
It is not known whether it is safe to consume alcohol with Kindsave Tablet. Please consult your doctor.
Kindsave Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kindsave Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Kindsave Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kindsave Tablet is safe to use in patients with kidney disease. No dose adjustment of Kindsave Tablet is recommended.
There is limited information available on the use of Kindsave Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Kindsave Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Mova Pharmaceutical Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: La Renon Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Croise Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sudha Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Albus Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Johnlee Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hospimax Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mexato Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kabir Life Sciences || ₹14.5/tablet (25% cheaper)